IQVIA Unveils New Custom AI Agents with NVIDIA

IQVIA Holdings Inc. (NYSE:IQV) is one of the most undervalued NYSE stocks to buy now. On June 11, IQVIA unveiled new custom-built AI agents at GTC Paris. These AI agents are developed in collaboration with NVIDIA Corp. (NASDAQ:NVDA) and are designed to streamline workflows and accelerate insights within the life sciences sector.

The initiative represents an advancement in how IQVIA’s Healthcare-grade AI platform uses agentic architectures to improve business processes and patient outcomes. The collaboration with NVIDIA involves using NVIDIA NIM Agent Blueprints for rapid development, NeMo Customizer for fine-tuning, and NeMo Guardrails for secure deployment of these AI agents.

IQVIA Unveils New Custom AI Agents with NVIDIA

A researcher in a lab with a microscope examining a sample.

The development builds upon a collaboration announced in January this year between IQVIA and NVIDIA. The initial partnership aimed to develop custom foundation models and agentic AI workflows to accelerate research, clinical development, and access to new treatments. Following GTC Paris, IQVIA plans to further explore the future of life sciences at its TechIQ 2025 conference.

IQVIA Holdings Inc. (NYSE:IQV) provides clinical research services, commercial insights, and healthcare intelligence to the life sciences & healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

While we acknowledge the potential of IQV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IQV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.